Keyword: Amgen

News

Amgen Raises 2013 EPS Forecast to Account for Tax Credit

07.02.2013 - Amgen, the world's largest biotechnology company, on Thursday raised its 2013 earnings forecast to account for a Puerto Rico excise tax credit due to federal settlements for prior...

News

Amgen 2013 Revenue Forecast Tops Street Estimates

24.01.2013 - Amgen on Wednesday projected revenue for 2013 that exceeds Wall Street estimates and said it was on track to deliver on its 2015 forecasts well ahead of schedule. The world's...

News

Amgen to Build Biotech Manufacturing Plant in Singapore

17.01.2013 - Amgen, the world's largest biotechnology company, announced on Wednesday plans to build a new manufacturing plant in Singapore. Thousand Oaks, California-based Amgen said it plans...

News

DSM Announces License Agreement with Amgen

16.01.2013 - DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that it has signed a non-exclusive license agreement with Amgen for...

News

Amgen Trims 2012 EPS Estimate, Citing R&D Tax Credit Delay

09.01.2013 - Amgen, the world's largest biotechnology company, on Tuesday lowered its outlook for 2012 earnings per share by 10 cents, citing a delay in the impact of a U.S. tax credit for...

News

U.S. Court Approves Amgen's $762 Million Payment in Drug Case

20.12.2012 - A federal judge on Wednesday approved a $762 million payment from Amgen, the final step to resolve nearly a dozen criminal and civil cases stemming from the sale of its once...

News

Amgen Pleads Guilty to Misbranding Charges, Will Pay $762 Million

18.12.2012 - Amgen pleaded guilty in a federal court in New York on Tuesday to misbranding its Aranesp anemia drug and agreed to pay $762 million in a civil settlement and criminal fines. The...

News

Amgen Buys Icelandic Gene Pioneer Decode for $415 Million

10.12.2012 - U.S. biotechnology group Amgen has agreed to buy unlisted Decode Genetics, a pioneer in gene research, for $415 million to boost its drive to develop better targeted drugs. Founded...